A patient on hemodialysis had an initial reactive hepatitis B surface antigen (HBsAg) screen, a repeat screen that was non‑reactive, and quantitative HBsAg results are pending; should the patient be dialyzed on a regular machine or be isolated on a separate dialysis machine until the quantitative result is available?

Management of Hemodialysis Patient with Discordant HBsAg Results

Until the quantitative HBsAg result confirms the patient is truly negative, you should isolate this patient and dialyze them on a separate machine to prevent potential HBV transmission to other patients and staff. 1

Rationale for Isolation Pending Confirmatory Testing

Why Isolation is Critical

• HBV transmission in dialysis units occurs through contaminated equipment, environmental surfaces, and direct contact, making isolation of potentially infected patients essential for infection control 1
• The initial reactive HBsAg test must be taken seriously despite the subsequent non-reactive result, as false-negative results can occur with certain HBsAg assays, particularly when HBV mutant strains are present 2, 3
• Mutant HBV infections can produce false-negative HBsAg results on standard testing platforms while patients remain highly infectious with detectable HBV DNA at high levels 2, 3
• Delayed identification of HBsAg-positive patients due to testing failures has historically led to HBV transmission in dialysis units, which is why CDC and CMS mandate strict isolation protocols 1, 4

The Problem with Discordant Results

• Transient HBsAg positivity can occur within 3 days to 4 weeks after HBV vaccination, which could explain discordant results if the patient was recently vaccinated 5
• However, you cannot assume vaccination is the cause without confirming the patient's recent vaccination history and timing 5
• Different HBsAg assay platforms have varying sensitivities for detecting mutant HBV strains, so a negative result on one assay does not definitively rule out infection 2
• The quantitative HBsAg test you ordered will help clarify whether this represents true infection, a mutant strain, or post-vaccination artifact 2, 6

Specific Actions While Awaiting Quantitative Results

Immediate Steps

• Dialyze the patient in an HBV isolation room on dedicated equipment until you have definitive confirmation of HBV status 1, 4, 7
• Assign staff who are anti-HBs positive (immune) to care for this patient if possible 7
• Obtain detailed vaccination history: specifically ask if the patient received HBV vaccine within the past 4 weeks 5
• Order additional confirmatory testing beyond quantitative HBsAg: include anti-HBc (IgM and total) and HBV DNA (if not already ordered) 1, 2

Interpreting the Pending Results

• If quantitative HBsAg is positive and HBV DNA is detectable at high levels with negative anti-HBc IgM, suspect mutant HBV infection requiring continued isolation 2, 3
• If quantitative HBsAg is positive but HBV DNA is negative/low and the patient was vaccinated within 4 weeks, this likely represents post-vaccination HBsAg detection rather than true infection 5
• If quantitative HBsAg is negative and HBV DNA is negative, the initial reactive test was likely a false positive and the patient can return to regular dialysis 1
• If HBV DNA is positive despite negative HBsAg on multiple platforms, strongly suspect mutant HBV and maintain isolation indefinitely 2, 3

Common Pitfalls to Avoid

• Do not screen patients for HBsAg within 1 week of HBV vaccination, and exercise caution interpreting results within 4 weeks of vaccination 5
• Do not rely solely on a single negative HBsAg result to rule out HBV infection when the initial test was reactive, especially without HBV DNA testing 2, 3
• Do not use HBsAg assays that cannot detect mutant HBV strains for routine screening; consider switching to more sensitive platforms 2
• Do not delay isolation procedures while awaiting confirmatory testing, as this creates unnecessary transmission risk to other dialysis patients 1, 4

Long-Term Management Based on Final Results

If Confirmed HBsAg-Positive

• Continue indefinite isolation on dedicated dialysis equipment 1, 4, 7
• Test for HBeAg and HBV DNA to assess infectivity level 7
• Notify public health authorities and conduct contact tracing of potentially exposed patients who dialyzed in proximity before isolation was implemented 2

If Confirmed HBsAg-Negative

• Return patient to regular dialysis schedule 1
• Continue monthly HBsAg screening if patient is HBV-susceptible (negative anti-HBs and anti-HBc) 1
• Document the discordant result and investigation in the medical record to inform future testing interpretation 2